BETHLEHEM, Pa., June 22, 2011 /PRNewswire/ -- In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I ...
BETHLEHEM, Pa., April 28 /PRNewswire/ -- Particle Sciences, Inc. today announced the appointment of Robert W. Lee, Ph.D. to the position of Vice President, Pharmaceutical Development. Dr. Lee joins ...
It's the world of ants like you've never seen it before! Dan Smith shows how biology and particle physics are teaming up in ...
Particle Sciences, Inc (PSI), has completed the manufacturing of clinical supplies for the first in human studies of KX2-361 (KX02), Kinex Pharmaceuticals’ small molecule Src/pre-tublin inhibitor.
🛍️ Amazon Prime Day: The best deals chosen by our editors 🛍️ By Rahul Rao Published Nov 2, 2023 5:00 PM EDT Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source ...
BETHLEHEM, Pa., April 1, 2014 /PRNewswire/ -- Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO), today announced that they have entered into an exclusive ...
Contract drug developer and manufacturer Particle Sciences Inc. has been renamed Lubrizol Life Science Health, five years after it was acquired by Lubrizol Corp. Lubrizol initially retained the name ...
Toxicology specialist Calvert Labs is joining forces with the formulation experts at Particle Sciences to offer an early-stage service package designed to speed up drug development. The collaboration ...
Some of the most fundamental questions about our universe are also the most difficult to answer. Questions like what gives matter its mass, what is the invisible 96 percent of the universe made of, ...
🛍️ Amazon Prime Day: The best deals chosen by our editors 🛍️ By Rahul Rao Published Jan 28, 2022 4:00 PM EST Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results